查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511940

兽用整形外科药物市场规模、份额和趋势分析报告：按产品类型、动物类型、应用、给药途径、最终用途、地区和细分市场预测，2024-2030年

Veterinary Orthopedic Medicines Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Application, By Route Of Administration, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 183 Pages | 商品交期: 2-10个工作天内

价格

整形外科市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球兽用整形外科药物市场规模将达28.7亿美元，2024年至2030年复合年增长率为8.6%。再生医学的出现、兽医学中越来越多地采用黏性补充以及宠物保险的快速增加是预计推动市场成长的一些关键因素。推动市场成长的其他因素包括兽医学的进步。根据勃林格殷格翰和美国动物医院协会 (AAHA) 进行的一项研究，五分之一的狗（即所有狗品种的 20%）在其一生中会经历某种类型的关节问题。大多数动物因发育性整形外科疾病（DOD）而患有骨关节炎（OA），某些犬种比其他犬种更容易出现关节畸形。

兽医再生医学旨在恢復患病或受损细胞和组织的正常功能，包括基于细胞的疗法等各种方法。间质基质细胞（MSC）、富血小板血浆（PRP）和自体血清製剂的使用在这个领域中很突出。这些治疗方法目前用于治疗狗、马和猫等动物的肌腱、韧带和关节/软骨。这些治疗主要以研究为基础，更具体的临床报告正在进行中。无论目前的用途如何，这一兽医分支都显示出有效治疗和管理兽医疾病的希望。

许多宠物饲主选择宠物保险来照顾宠物的健康。根据《今日美国》 2024 年 2 月的一篇报导，大约 26% 的受访美国人表示，他们每月在狗身上花费 51 至 100 美元。另一方面，有些宠物保险公司承保一定数量的处方药。 Fetch Pet 药物保险是为疾病和意外提供单一计划的保险计划之一。该计划承保承保病症的所有处方药，包括先天性和整形外科病症等慢性病。根据北美宠物健康保险协会（NAPHIA）统计，截至2023年，美国已购买价值约32亿美元的宠物保险，到2022年终，美国将有约480万隻宠物投保。此外，《富比士》估计，到 2023 年，因疾病或骨折等问题前往兽医院紧急就诊的费用可能约为 1,000 美元。

这是 1,000 美元。因此，宠物保险是弥补意外医疗费用的必要工具。

目前的再生疗法如MSC和PRP属于药物类别。因此，FDA 将它们归入「细胞产品」类别下进行监管。然而，迄今为止，这些治疗方法均未获得 FDA核准，且它们目前的使用属于 FDA 的临床实验豁免范围。此外，技术进步透过引入创新的治疗方法和程序彻底改变了兽医整形外科医学。先进的诊断影像、基因编辑和干细胞治疗等新技术可以对动物健康进行更精确、更有效的干预。这些创新提高了兽医的诊断和治疗能力，并为以前难以治疗的病症提供了先进的解决方案。

整形外科骨科市场报告亮点

  • 製药领域在 2023 年以 46.5% 的份额占据市场主导地位，因为 NSAIDS 和类固醇等产品经常用于治疗兽医整形外科併发症。
  • 由于犬类骨关节炎的高盛行率、高市场采用率以及犬类运动伤害数量的增加，预计犬类市场在预测期内将以最快的复合年增长率增长。
  • 2023年OA领域占最大市场占有率。
  • 然而，关节发炎/疼痛部分预计在预测期内将呈现最快的增长。
  • 由于 OA 盛行率不断上升、兽医医疗基础设施设备齐全、政府对优质兽医医疗保健的支持以及美国宠物拥有量的增加，北美在全球兽医整形外科市场中占据主导地位。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章整形外科药品市场的变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 整形外科骨科市场分析工具
    • 波特的分析
    • PESTEL分析

第四章整形外科骨科市场：产品评估与趋势分析

  • 2023 年和 2030 年按动物类型分類的市场占有率份额
  • 细分仪表板
  • 整形外科骨科市场：产品展望
  • 2018-2030年市场规模、预测及趋势分析
  • 生物製药
  • 黏性补充品
  • 药品

第五章整形外科药品市场：依动物类型估计及趋势分析

  • 2023 年和 2030 年按动物类型分類的市场占有率份额
  • 细分仪表板
  • 整形外科骨科市场：依动物种类分類的前景
  • 2018-2030年市场规模、预测及趋势分析
  • 狗
  • 马
  • 其他的

第六章整形外科药品市场：应用预估及趋势分析

  • 2023年及2030年应用市场占有率
  • 细分仪表板
  • 整形外科骨科市场：应用前景
  • 骨关节炎
  • 骨关节炎（DJD）
  • 其他用途

第七章整形外科药品市场：给药途径预估及趋势分析

  • 2023 年及 2030 年给药途径市场占有率
  • 细分仪表板
  • 整形外科骨科市场：给药途径展望
  • 口服
  • 可注射的
  • 其他的

第八章整形外科骨科市场：最终用途估计和趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 整形外科市场：最终用户展望
  • 动物医院
  • 兽医诊所
  • 其他的

第九章整形外科骨科市场：区域估计和趋势分析

  • 2023年及2030年按地区分類的整形外科骨科市场占有率
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 公司市场占有率分析
  • 企业热力图分析
  • 策略规划
    • 扩张
    • 併购
    • 伙伴关係与协作
    • 新产品发布
    • 研究与开发
  • 公司简介
    • Zoetis Inc.
    • Boehringer Ingelheim
    • Elanco Animal Health
    • American Regent, Inc.
    • Merck Animal Health（Merck &Co. Inc）
    • Vetoquinol SA
    • Ceva Sante Animale
    • Virbac
    • Biogenesis Bago
    • Ardent Animal Health LLC.
    • Bioiberica SAU
    • PetVivo Holdings, Inc.（Spryng）
    • Contipro AS
    • VetStem, Inc.
    • Enso Discoveries
    • Contura Vet US
    • T-Cyte Therepeutics
    • MEDREGO LLC
    • Bimeda US
    • Hyalogic
    • Hester Biosciences
Product Code: GVR-4-68040-167-6

Veterinary Orthopedic Medicines Market Growth & Trends:

The global veterinary orthopedic medicines market size is expected to reach USD 2.87 billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The emergence of regenerative medicine, the rise in adoption of viscosupplements in veterinary medicine, and the surge in uptake of pet insurance are some of the major factors expected to propel market growth. Other factors fueling market growth include advancements in veterinary medicine. According to a study conducted by Boehringer Ingelheim and the American Animal Hospital Association (AAHA), 1 in 5 five dogs, i.e., 20% of all dogs, experience some kind of joint issue in their lifetime. A majority of animals suffer from Osteoarthritis (OA) due to Developmental Orthopedic Diseases (DODs), with certain breeds more prone to malformed joints than others.

Regenerative medicine in veterinary medicine aims to restore normal function of diseased or damaged cells, tissues, etc., including different approaches like cell-based therapies. The use of Mesenchymal Stromal Cells (MSCs), Platelet-rich Plasma (PRP), and autologous serum products is prominent in this field. Currently, these therapies are used in the treatment of tendon, ligament, and joint/cartilage in animals like dogs, horses, & cats. These treatments are primarily research-based, and further concrete clinical reports are under progress. Irrespective of the current use, this branch of veterinary medicine is showing promise for effective treatment & management of veterinary diseases.

Most pet owners are opting for pet insurance to manage the health expenses of their pets. According to a February 2024 article by USA Today, around 26% of the Americans surveyed stated they spend between USD 51 and USD 100 a month on their dogs. On the other hand, several pet insurance companies cover a certain amount of prescription medication. Fetch Pet medication coverage is one of the insurance plans that offers a single plan for illnesses and accidents. The plan covers all prescription drugs for covered conditions, including congenital and chronic ailments like orthopedic problems. According to the North American Pet Health Insurance Association (NAPHIA), as of 2023, there were pet insurance policies worth around USD 3.2 billion in the U.S. Comparably, there were around 4.8 million insured pets in the U.S. at the end of 2022, which was a 22% rise since 2021. Moreover, according to Forbes estimates, in 2023, a veterinary emergency visit for challenges, such as ailments or a broken bone, might cost around

USD 1,000. Hence, pet insurance is a necessary tool for covering unforeseen medical expenses.

Current regenerative therapies like MSCs, PRP, etc., fall under the category of drugs. Hence, the FDA regulates them under the category "Cell-based Products"; however, no FDA approval has been given to any of these therapies till now, and the current use falls under FDA investigational exemption. In addition, technological advancements revolutionized veterinary orthopedic medicine by introducing innovative treatments and procedures. Novel technologies, such as advanced imaging, gene editing, and stem cell therapies, enable more precise & effective interventions in animal health. These technological breakthroughs enhance the diagnostic and treatment capabilities of veterinarians, providing advanced solutions for conditions that were previously challenging to address.

Veterinary Orthopedic Medicines Market Report Highlights:

  • The pharmaceuticals segment dominated the market with a 46.5% share in 2023 due to the high adoption of products, such as NSAIDS, steroids, etc., in the treatment of veterinary orthopedic complications.
  • The canine segment is expected to grow at the fastest CAGR over the forecast period due to the high prevalence of OA in dogs, the high market adoption, and the rise in sports injuries among dogs.
  • The OA segment held the largest market share in 2023.
  • However, the joint inflammation/pain segment is anticipated to witness the fastest growth over the forecast period.
  • North America dominated the global veterinary orthopedic medicines market due to the increasing prevalence of OA, well-equipped veterinary care infrastructure, government support for quality animal care, and increasing pet adoption in the U.S.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal Type
    • 1.2.3. Application
    • 1.2.4. Route of administration
    • 1.2.5. End Use
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product
    • 2.2.2. Animal Type
    • 2.2.3. Application
    • 2.2.4. Route of administration
    • 2.2.5. End Use
    • 2.2.6. Regional scope
  • 2.3. Competitive Insights

Chapter 3. Veterinary Orthopedic Medicines Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising prevalence of orthopedic problems
      • 3.2.1.2. Growing uptake of pet insurance
      • 3.2.1.3. Increase in ageing animal population
      • 3.2.1.4. Advancements in veterinary orthopedic medicines
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Shortage of veterinarians
      • 3.2.2.2. High treatment cost
  • 3.3. Veterinary Orthopedic Medicines Market Analysis Tools
    • 3.3.1. Porter's Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Veterinary Orthopedic Medicines Market: Product Estimates & Trend Analysis

  • 4.1. Animal Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Veterinary Orthopedic Medicines Market: Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Biologics
    • 4.5.1. Biologics Market, 2018 to 2030 (USD Million)
  • 4.6. Viscosupplements
    • 4.6.1. Viscosupplements Market, 2018 to 2030 (USD Million)
  • 4.7. Pharmaceuticals
    • 4.7.1. Pharmaceuticals Market, 2018 to 2030 (USD Million)

Chapter 5. Veterinary Orthopedic Medicines Market: Animal Type Estimates & Trend Analysis

  • 5.1. Animal Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Veterinary Orthopedic Medicines Market: Animal Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Canine
    • 5.5.1. Canine Market, 2018 to 2030 (USD Million)
  • 5.6. Equine
    • 5.6.1. Equine Market, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2018 to 2030 (USD Million)

Chapter 6. Veterinary Orthopedic Medicines Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Veterinary Orthopedic Medicines Market: Application Outlook
  • 6.4. Osteoarthritis
    • 6.4.1. Osteoarthritis Market, 2018 to 2030 (USD Million)
  • 6.5. Degenerative Joint Disease (DJD)
    • 6.5.1. Degenerative Joint Disease (DJD) Market, 2018 to 2030 (USD Million)
  • 6.6. Other Applications
    • 6.6.1. Other Applications Market, 2018 to 2030 (USD Million)

Chapter 7. Veterinary Orthopedic Medicines Market: Route of Administration Estimates & Trend Analysis

  • 7.1. Route of Administration Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Veterinary Orthopedic Medicines Market: Route of Administration Outlook
  • 7.4. Oral
    • 7.4.1. Oral Market, 2018 to 2030 (USD Million)
  • 7.5. Injectable
    • 7.5.1. Injectable Market, 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2018 to 2030 (USD Million)

Chapter 8. Veterinary Orthopedic Medicines Market: End use Estimates & Trend Analysis

  • 8.1. End Use Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Veterinary Orthopedic Medicines Market: End user Outlook
  • 8.4. Veterinary Hospitals
    • 8.4.1. Veterinary Hospitals Market, 2018 to 2030 (USD Million)
  • 8.5. Veterinary Clinics
    • 8.5.1. Veterinary Clinics Market, 2018 to 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market, 2018 to 2030 (USD Million)

Chapter 9. Veterinary Orthopedic Medicines Market: Regional Estimates & Trend Analysis

  • 9.1. Veterinary Orthopedic Medicines Market Share, By Region, 2023 & 2030 (USD Million)
  • 9.2. North America
    • 9.2.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
  • 9.3. Europe
    • 9.3.1. Europe Market Estimates and Forecasts, 2018 - 2030
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France Market Estimates and Forecasts, 2018 - 2030
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 9.3.7. Denmark
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 9.3.8. Sweden
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway Market Estimates and Forecasts, 2018 - 2030
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030
    • 9.4.2. Japan
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 9.4.3. China
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India Market Estimates and Forecasts, 2018 - 2030
    • 9.4.5. Australia
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
    • 9.4.6. Thailand
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
    • 9.4.7. South Korea
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. South Korea Market Estimates and Forecasts, 2018 - 2030
  • 9.5. Latin America
    • 9.5.1. Latin America Market Estimates and Forecasts, 2018 - 2030
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Mexico Market Estimates and Forecasts, 2018 - 2030
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.4.3. Competitive Insights
      • 9.5.4.4. Argentina Market Estimates and Forecasts, 2018 - 2030
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
    • 9.6.2. South Africa
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 9.6.4. UAE
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Market Share Analysis
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. Zoetis Inc.
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. Boehringer Ingelheim
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. Elanco Animal Health
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. American Regent, Inc.
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. Merck Animal Health (Merck & Co. Inc)
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. Vetoquinol S.A.
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Ceva Sante Animale
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. Virbac
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Biogenesis Bago
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Ardent Animal Health LLC.
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments
    • 10.6.11. Bioiberica S.A.U
      • 10.6.11.1. Participant's Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Recent Developments
    • 10.6.12. PetVivo Holdings, Inc. (Spryng)
      • 10.6.12.1. Participant's Overview
      • 10.6.12.2. Financial Performance
      • 10.6.12.3. Product Benchmarking
      • 10.6.12.4. Recent Developments
    • 10.6.13. Contipro A.S.
      • 10.6.13.1. Participant's Overview
      • 10.6.13.2. Financial Performance
      • 10.6.13.3. Product Benchmarking
      • 10.6.13.4. Recent Developments
    • 10.6.14. VetStem, Inc.
      • 10.6.14.1. Participant's Overview
      • 10.6.14.2. Financial Performance
      • 10.6.14.3. Product Benchmarking
      • 10.6.14.4. Recent Developments
    • 10.6.15. Enso Discoveries
      • 10.6.15.1. Participant's Overview
      • 10.6.15.2. Financial Performance
      • 10.6.15.3. Product Benchmarking
      • 10.6.15.4. Recent Developments
    • 10.6.16. Contura Vet US
      • 10.6.16.1. Participant's Overview
      • 10.6.16.2. Financial Performance
      • 10.6.16.3. Product Benchmarking
      • 10.6.16.4. Recent Developments
    • 10.6.17. T-Cyte Therepeutics
      • 10.6.17.1. Participant's Overview
      • 10.6.17.2. Financial Performance
      • 10.6.17.3. Product Benchmarking
      • 10.6.17.4. Recent Developments
    • 10.6.18. MEDREGO LLC
      • 10.6.18.1. Participant's Overview
      • 10.6.18.2. Financial Performance
      • 10.6.18.3. Product Benchmarking
      • 10.6.18.4. Recent Developments
    • 10.6.19. Bimeda U.S.
      • 10.6.19.1. Participant's Overview
      • 10.6.19.2. Financial Performance
      • 10.6.19.3. Product Benchmarking
      • 10.6.19.4. Recent Developments
    • 10.6.20. Hyalogic
      • 10.6.20.1. Participant's Overview
      • 10.6.20.2. Financial Performance
      • 10.6.20.3. Product Benchmarking
      • 10.6.20.4. Recent Developments
    • 10.6.21. Hester Biosciences
      • 10.6.21.1. Participant's Overview
      • 10.6.21.2. Financial Performance
      • 10.6.21.3. Product Benchmarking
      • 10.6.21.4. Recent Developments

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 North America Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 North America Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 North America Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 6 North America Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 7 North America Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 8 North America Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 U.S. Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 12 U.S. Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 13 U.S. Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Canada Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 17 Canada Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 18 Canada Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
  • Table 20 Europe Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Europe Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 23 Europe Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 Europe Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 25 UK Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 UK Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 27 UK Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 28 UK Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 29 UK Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 30 Germany Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 32 Germany Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 33 Germany Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 34 Germany Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 35 France Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 France Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 37 France Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 38 France Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 39 France Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 40 Italy Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 41 Italy Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 42 Italy Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 43 Italy Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 44 Italy Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 45 Spain Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Spain Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 47 Spain Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 48 Spain Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 49 Spain Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 50 Denmark Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Denmark Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 52 Denmark Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 53 Denmark Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 54 Denmark Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 55 Sweden Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 Sweden Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 57 Sweden Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 58 Sweden Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 59 Sweden Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 60 Norway Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 61 Norway Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 62 Norway Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 63 Norway Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 64 Norway Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 71 China Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 72 China Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 73 China Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 74 China Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 75 China Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 76 Japan Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 77 Japan Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 78 Japan Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 79 Japan Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 80 Japan Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 81 India Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 82 India Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 83 India Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 84 India Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 India Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 86 Australia Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 87 Australia Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 88 Australia Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 89 Australia Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 90 Australia Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 91 South Korea Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 92 South Korea Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 93 South Korea Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 94 South Korea Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 95 South Korea Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 96 Thailand Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 97 Thailand Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 98 Thailand Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 99 Thailand Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 100 Thailand Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 101 Latin America Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
  • Table 102 Latin America Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 103 Latin America Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 104 Latin America Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 105 Latin America Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 106 Latin America Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 107 Brazil Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 108 Brazil Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 109 Brazil Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 110 Brazil Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 111 Brazil Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 112 Mexico Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 113 Mexico Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 114 Mexico Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 115 Mexico Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 116 Mexico Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 117 Argentina Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 118 Argentina Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 119 Argentina Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 120 Argentina Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 121 Argentina Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 122 MEA Veterinary Orthopedic Medicines Market, By Region, 2018 - 2030 (USD Million)
  • Table 123 MEA Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 124 MEA Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 125 MEA Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 126 MEA Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 127 MEA Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 128 South Africa Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 129 South Africa Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 130 South Africa Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 131 South Africa Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 132 South Africa Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 137 Saudi Arabia Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 138 UAE Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 139 UAE Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 140 UAE Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 141 UAE Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 142 UAE Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)
  • Table 143 Kuwait Veterinary Orthopedic Medicines Market, By Product, 2018 - 2030 (USD Million)
  • Table 144 Kuwait Veterinary Orthopedic Medicines Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 145 Kuwait Veterinary Orthopedic Medicines Market, Application, 2018 - 2030 (USD Million)
  • Table 146 Kuwait Veterinary Orthopedic Medicines Market, Route of Administration, 2018 - 2030 (USD Million)
  • Table 147 Kuwait Veterinary Orthopedic Medicines Market, End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Veterinary Orthopedic Medicines Market Segmentation
  • Fig. 2 Disease Epidemiology
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (1/2)
  • Fig. 9 Segment Snapshot (2/2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 Veterinary Orthopedic Medicines - Market Size and Growth Prospects (USD Million)
  • Fig. 12 Veterinary Orthopedic Medicines Market: Industry Value Chain Analysis
  • Fig. 13 Veterinary Orthopedic Medicines Market: Market Dynamics
  • Fig. 14 Veterinary Orthopedic Medicines Market: PORTER's Analysis
  • Fig. 15 Veterinary Orthopedic Medicines Market: PESTEL Analysis
  • Fig. 16 Veterinary Orthopedic Medicines Market Share By Product, 2023 & 2030 (USD Million)
  • Fig. 17 Veterinary Orthopedic Medicines Market, By Product: Market Share, 2023 & 2030
  • Fig. 18 Biologics Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 19 Viscosupplements Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 20 Pharmaceuticals Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 21 Veterinary Orthopedic Medicines Market Share By Animal type, 2023 & 2030 (USD Million)
  • Fig. 22 Veterinary Orthopedic Medicines Market, By Animal type: Market Share, 2023 & 2030
  • Fig. 23 Canine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 24 Equine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 25 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 26 Veterinary Orthopedic Medicines Market Share By Application, 2023 & 2030 (USD Million)
  • Fig. 27 Veterinary Orthopedic Medicines Market, By Application: Market Share, 2023 & 2030
  • Fig. 28 Osteoarthritis Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 29 Degenerative Joint Diseases (DJD) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 30 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 31 Veterinary Orthopedic Medicines Market Share By Route of Administration, 2023 & 2030 (USD Million)
  • Fig. 32 Veterinary Orthopedic Medicines Market, By Route of Administration: Market Share, 2023 & 2030
  • Fig. 33 Oral Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 34 Injectable Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 35 Veterinary Orthopedic Medicines Market, by End User: Key Takeaways
  • Fig. 36 Veterinary Orthopedic Medicines Market, by End User: Market Share, 2023 & 2030
  • Fig. 37 Veterinary Hospitals Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 38 Veterinary Clinics Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 39 Other Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 40 Fig. 39 Veterinary Orthopedic Medicines Market Revenue, by Region, 2023 & 2030 (USD Million)
  • Fig. 41 Regional Marketplace: Key Takeaways
  • Fig. 42 Regional Marketplace: Key Takeaways
  • Fig. 43 North America Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 UK Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
  • Fig. 48 Germany Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Norway Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific Veterinary Orthopedic Medicines Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 56 China Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Japan Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 India Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Mexico Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 MEA Market Estimates and Forecasts, 2018 - 2030
  • Fig. 67 KSA Market Estimates and Forecasts, 2018 - 2030
  • Fig. 68 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 69 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 70 Kuwait Market Estimates and Forecasts, 2018 - 2030